US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 14.220
  • 0.0000.00%
Close Nov 5 15:59 ET
  • 13.610
  • -0.610-4.29%
Pre 08:46 ET
45.25BMarket Cap23.70P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com

Company Executives

  • Name
  • Position
  • Salary
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Infectious Disease
Infectious Disease
Intraday0.00%